Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind (Sponsor Open) Placebo-controlled, Stratified, Parallel Group Study to Evaluate the Efficacy and Safety of Repeat Doses of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)

NCT03393806 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03393806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03393806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind (Sponsor Open) Placebo-controlled, Stratified, Parallel Group Study to Evaluate the Efficacy and Safety of Repeat Doses of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
April 18, 2018
Completion date
January 6, 2020
Enrollment
17 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

asthma